by John Conrad | Jun 21, 2024 | iBIO News
In a celebration of innovation and entrepreneurship in the life sciences sector, the Illinois Biotechnology Innovation Organization (iBIO) has named Rheoxtech as the winner of the first-ever Timothy P. Walbert Entrepreneurship Impact Award. The announcement came...
by John Conrad | Jun 21, 2024 | iBIO News
Illinois Biotechnology Innovation Organization Announces Rheoxtech as Winner of Inaugural Timothy P. Walbert Entrepreneurship Impact Award CHICAGO, IL (June 21, 2024) – The Illinois Biotechnology Innovation Organization (iBIO) is pleased to announce that Rheoxtech has...
by John Conrad | Jun 18, 2024 | iBIO News
iBIO Adds Accomplished Communications and Manufacturing Leaders to Board of Directors CHICAGO (June 18, 2024) The Illinois Biotechnology Innovation Organization (iBIO), the trade association representing the 91,000 jobs in Illinois’ life sciences sector, today...
by John Conrad | Jun 17, 2024 | NewsBrief
John Flavin, CEO of Portal Innovations, recently appeared on CNBC’s Fast Money to discuss GLP-1 drugs, early-stage biotech investing, and Portal’s unique investment model. On the topic of GLP-1 drugs for obesity and diabetes, Flavin noted that while there...
by John Conrad | Jun 17, 2024 | iBIO News
John F. Crowley is a man on a mission. As the newly appointed President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group, Crowley brings a unique blend of personal passion and professional expertise to...
